Randomized Phase Ii-Iii Study Of Bevacizumab In Combination With Chemotherapy In Previously Untreated Extensive Small-Cell Lung Cancer: Results From The Ifct-0802 Trial.
Annals of Oncology（2014）
摘要
IFCT study administering 7.5 mg/kg Bevacizumab plus chemotherapy after chemotherapy induction did not improve outcomes in extensive SCLC patients.
更多查看译文
关键词
small-cell lung cancer,chemotherapy,anti-angiogenesis therapy,bevacizumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要